All Stories

  1. Lupeol- and Cis-Vaccenic Acid-Containing Bioactive Fraction of Mondia whitei Induces Vacuolation-Associated Cytotoxicity Through Autophagy–Lysosome Perturbation and Caspase-Dependent Apoptosis in Human Colorectal Adenocarcinoma Cells
  2. Integrative drug discovery through molecular, cellular, genomic, and immunological approaches: From gene editing to precision antibody engineering
  3. The cGAS–STING pathway in cancer immunotherapy: prognostic value and therapeutic potential
  4. Burden of cancer attributable to occupational asbestos exposure in the Americas, 1990–2023: an analysis using the Global Burden of Disease Study 2023
  5. Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  6. Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990–2023: a Global Burden of Disease study
  7. Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
  8. Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021
  9. Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  10. Exosomal Nanocarriers of Immune Fate: Molecular Insights into Cancer Immunity, Pathogen Defense, and Emerging Immunotherapies
  11. The immunological impact of exosomes: modulation and mechanisms
  12. Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  13. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  14. HIV / AIDS in transition: Global disparities, Africa's uneven progress and struggles, and the emerging threat of funding cuts (global burden of disease study, 1990–2021)
  15. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  16. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  17. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
  18. Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis
  19. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
  20. GBD 2023 Cardiovascular Disease Collaborators
  21. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  22. Rising global threat of human metapneumovirus (hMPV in 2024/2025): pathogenesis, immune dynamics, vulnerabilities in immunocompromised individuals, and lessons from past pandemics
  23. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  24. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  25. Anti-proliferative effects of a polyherbal formulation on HL-60, HCT-116, and HeLa cell lines: a docking simulation and response surface design-aided study
  26. 2024 Acknowledgment of Microbiology Spectrum Ad Hoc Reviewers
  27. From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy
  28. Melatonin and its derivatives
  29. Expression Patterns of ER, PR, HER-2/neu and p53 in Association with Nottingham Tumour Grade in Breast Cancer Patients
  30. Multi-Fold Computational Analysis to Explore JAK2 and STAT5 Potential Inhibitors for Modulation of Cancer
  31. EMT-induced immune evasion: connecting the dots from mechanisms to therapy
  32. Nanodelivery of Polyphenols as Nutraceuticals in Anticancer Interventions
  33. Antipyretic Agents from Plant Origins
  34. Phytochemicals and bioactive compounds effective against acute myeloid leukemia: A systematic review
  35. Wnt/β‐catenin signaling pathway inhibitors, glycyrrhizic acid, solanine, polyphyllin I, crocin, hypericin, tubeimoside‐1, diosmin, and rutin in medicinal plants have better binding affinities and anticancer properties: Molecular docking and ADMET<...
  36. The Roles of Oxylipin Biosynthesis Genes in Programmed Cell Death
  37. Therapeutic potentials of medicinal plants and significance of computational tools in anti-cancer drug discovery
  38. Synchronicity of P53 Mutation and Multiple High-Risk HPV Genotypes, and the Risk of Cervical Cancer among Women in Osogbo, Nigeria
  39. Understanding the Complex Milieu of Epithelial-Mesenchymal Transition in Cancer Metastasis: New Insight Into the Roles of Transcription Factors
  40. Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion
  41. Addressing the global surge of COVID-19 cases: insights from diagnostics, improved treatment strategies, vaccine development and application
  42. Ebola outbreak in West Africa, 2014 – 2016: Epidemic timeline, differential diagnoses, determining factors, and lessons for future response
  43. A close look at the biology of SARS-CoV-2, and the potential influence of weather conditions and seasons on COVID-19 case spread
  44. Public health preparedness towards COVID-19 outbreak in Nigeria
  45. Prostate Tuberculosis
  46. Glycemic control and its impact on oxidative stress biomarkers in type 2 diabetic patients treated with metformin: a cross-sectional analysis
  47. Assessment of iron status and interplay between lipid peroxidation and antioxidant capacity in common hemoglobin variants in Osun State, southwestern Nigeria
  48. Antioxidant and chemotherapeutic effects of trèvo®supplement on benzene-induced leukaemia in murine models
  49. In-vitro anti-sickling and membrane stability potentials of Mishenland polyherbal extract on sickle red blood cells
  50. Hepatoprotective Potential of Russelia Equisetiformis Plant Extract on Drug-Induced Hepatotoxicity in Experimental Models
  51. CD4+ Cell Count, Lipid And Lipoprotein Levels In Hiv Patients On Drug Treatment